ORIC Pharmaceuticals Inc [NASDAQ: ORIC] gained 1.41% or 0.15 points to close at $10.8 with a heavy trading volume of 348771 shares.
It opened the trading session at $10.73, the shares rose to $10.88 and dropped to $10.6, the range by which the price of stock traded the whole day. The daily chart for ORIC points out that the company has recorded 32.19% gains over the past six months.
If we look at the average trading volume of 1.22M shares, ORIC reached to a volume of 348771 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about ORIC Pharmaceuticals Inc [ORIC]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ORIC shares is $19.56 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ORIC stock is a recommendation set at 1.10. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Wells Fargo have made an estimate for ORIC Pharmaceuticals Inc shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on October 31, 2024. While these analysts kept the previous recommendation, Stifel raised their target price to Buy. The new note on the price target was released on September 06, 2024, representing the official price target for ORIC Pharmaceuticals Inc stock.
The Price to Book ratio for the last quarter was 3.49, with the Price to Cash per share for the same quarter was set at 2.39.
Trading performance analysis for ORIC stock
ORIC Pharmaceuticals Inc [ORIC] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 2.86. With this latest performance, ORIC shares gained by 28.57% in over the last four-week period, additionally plugging by 32.19% over the last 6 months – not to mention a rise of 33.83% in the past year of trading.
ORIC Pharmaceuticals Inc [ORIC]: A deeper dive into fundamental analysis
Return on Equity for this stock declined to -44.76%, with Return on Assets sitting at -44.76%.
ORIC Pharmaceuticals Inc [ORIC]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ORIC. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for ORIC Pharmaceuticals Inc go to 3.17%.
An analysis of Institutional ownership at ORIC Pharmaceuticals Inc [ORIC]
There are presently around $102.70%, or 111.54% of ORIC stock, in the hands of institutional investors. The top three institutional holders of ORIC stocks are: NEXTECH INVEST LTD. with ownership of 5.29 million shares, which is approximately 7.5136%. FMR LLC, holding 4.92 million shares of the stock with an approximate value of $$34.79 million in ORIC stocks shares; and FMR LLC, currently with $$34.15 million in ORIC stock with ownership which is approximately 6.8671%.
